Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Mouse Anti-JPH2 Recombinant Antibody (2E5) (CBMAB-0145-WJ)


See all JPH2 antibodies
Online Inquiry

Summary

Host Animal
Mouse
Specificity
Human
Clone
2E5
Antibody Isotype
IgG2a
Application
WB

Basic Information

Immunogen
Full length recombinant protein of human JPH2.
Specificity
Human
Antibody Isotype
IgG2a
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
JPH2
Introduction
JPH2 (Junctophilin 2) is a Protein Coding gene encodes the protein which is a component of junctional complexes and is composed of a C-terminal hydrophobic segment spanning the endoplasmic/sarcoplasmic reticulum membrane and a remaining cytoplasmic domain that shows specific affinity for the plasma membrane. Diseases associated with JPH2 include Cardiomyopathy, Familial Hypertrophic, 17 and Lung Abscess.
Entrez Gene ID
57158
UniProt ID
Q9BR39
Alternative Names
JP2; JP-2; CMH17
Function
Junctophilin-2
Membrane-binding protein that provides a structural bridge between the plasma membrane and the sarcoplasmic reticulum and is required for normal excitation-contraction coupling in cardiomyocytes (PubMed:20095964).
Provides a structural foundation for functional cross-talk between the cell surface and intracellular Ca(2+) release channels by maintaining the 12-15 nm gap between the sarcolemma and the sarcoplasmic reticulum membranes in the cardiac dyads (By similarity).
Necessary for proper intracellular Ca(2+) signaling in cardiac myocytes via its involvement in ryanodine receptor-mediated calcium ion release (By similarity).
Contributes to the construction of skeletal muscle triad junctions (By similarity).
Junctophilin-2 N-terminal fragment
Transcription repressor required to safeguard against the deleterious effects of cardiac stress. Generated following cleavage of the Junctophilin-2 chain by calpain in response to cardiac stress in cardiomyocytes. Following cleavage and release from the membrane, translocates to the nucleus, binds DNA and represses expression of genes implicated in cell growth and differentiation, hypertrophy, inflammation and fibrosis. Modifies the transcription profile and thereby attenuates pathological remodeling in response to cardiac stress. Probably acts by competing with MEF2 transcription factors and TATA-binding proteins.
Biological Process
Calcium ion homeostasisManual Assertion Based On ExperimentIDA:UniProtKB
Calcium ion transport into cytosolManual Assertion Based On ExperimentTAS:BHF-UCL
Negative regulation of transcription by RNA polymerase IIISS:UniProtKB
Negative regulation of transcription, DNA-templatedISS:UniProtKB
Positive regulation of ryanodine-sensitive calcium-release channel activityManual Assertion Based On ExperimentIDA:UniProtKB
Regulation of cardiac muscle tissue developmentIEA:Ensembl
Regulation of ryanodine-sensitive calcium-release channel activityManual Assertion Based On ExperimentTAS:BHF-UCL
Cellular Location
Junctophilin-2: Cell membrane; Sarcoplasmic reticulum membrane; Endoplasmic reticulum membrane. The transmembrane domain is anchored in sarcoplasmic reticulum membrane, while the N-terminal part associates with the plasma membrane. In heart cells, it predominantly associates along Z lines within myocytes. In skeletal muscle, it is specifically localized at the junction of A and I bands.
Junctophilin-2 N-terminal fragment: Nucleus. Accumulates in the nucleus of stressed hearts.
Involvement in disease
Cardiomyopathy, familial hypertrophic 17 (CMH17):
A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.
Topology
Cytoplasmic: 1-674
Helical: 675-695
PTM
Phosphorylation on Ser-165, probably by PKC, affects RYR1-mediated calcium ion release, interaction with TRPC3, and skeletal muscle myotubule development.
Proteolytically cleaved by calpain in response to cardiac stress. The major cleavage site takes place at the C-terminus and leads to the release of the Junctophilin-2 N-terminal fragment chain (JP2NT).
More Infomation

Parker, L. E., Kramer, R. J., Kaplan, S., & Landstrom, A. P. (2023). One gene, two modes of inheritance, four diseases: A systematic review of the cardiac manifestation of pathogenic variants in JPH2-encoded junctophilin-2. Trends in Cardiovascular Medicine, 33(1), 1-10.

Luo, T., Yan, N., Xu, M., Dong, F., Liang, Q., Xing, Y., & Fan, H. (2022). Junctophilin-2 allosterically interacts with ryanodine receptor type 2 to regulate calcium release units in mouse cardiomyocytes. General Physiology & Biophysics, 41(2).

Gross, P., Johnson, J., Romero, C. M., Eaton, D. M., Poulet, C., Sanchez-Alonso, J., ... & Houser, S. R. (2021). Interaction of the joining region in junctophilin-2 with the L-type Ca2+ channel is pivotal for cardiac dyad assembly and intracellular Ca2+ dynamics. Circulation research, 128(1), 92-114.

Poulet, C., Sanchez-Alonso, J., Swiatlowska, P., Mouy, F., Lucarelli, C., Alvarez-Laviada, A., ... & Gorelik, J. (2021). Junctophilin-2 tethers T-tubules and recruits functional L-type calcium channels to lipid rafts in adult cardiomyocytes. Cardiovascular research, 117(1), 149-161.

Jiang, M., Hu, J., White, F. K., Williamson, J., Klymchenko, A. S., Murthy, A., ... & Tseng, G. N. (2019). S-Palmitoylation of junctophilin-2 is critical for its role in tethering the sarcoplasmic reticulum to the plasma membrane. Journal of Biological Chemistry, 294(36), 13487-13501.

Jones, E. G., Mazaheri, N., Maroofian, R., Zamani, M., Seifi, T., Sedaghat, A., ... & Landstrom, A. P. (2019). Analysis of enriched rare variants in JPH2-encoded junctophilin-2 among Greater Middle Eastern individuals reveals a novel homozygous variant associated with neonatal dilated cardiomyopathy. Scientific reports, 9(1), 9038.

Vanninen, S. U., Leivo, K., Seppälä, E. H., Aalto-Setälä, K., Pitkänen, O., Suursalmi, P., ... & Koskenvuo, J. W. (2018). Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure. PLoS One, 13(9), e0203422.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-JPH2 Recombinant Antibody (2E5)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Request bulk or custom quoteOnline Inquiry
Second antibody and isotype control

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Online Inquiry